05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
Last November, Arizona’s Court of Appeals issued a memorandum decision analyzing Arizona’s Prompt ...
Read More >
Amazon is a mover and shaker in e-commerce and they have a pretty large 401(k) plan now. As of the e...
Read More >
Presented by Cohen Seglias attorney Michael F. McKenna on December 3, 2020. Over the past few decad...
Read More >
This week, the U.S. Department of Labor (DOL) published its highly anticipated Final Rule, which all...
Read More >
The Equality and Human Rights Commission has issued guidance on the use of confidentiality provision...
Read More >
On December 18, 2019, Chancellor Andre G. Bouchard of the Delaware Court of Chancery ruled that defe...
Read More >